Dana Hu-Lowe
Corporate Officer/Principal presso ADAGENE INC.
Profilo
Dana Hu-Lowe's current job is Vice President-Global Product at Adagene, Inc. Dr. Hu-Lowe's former jobs include Executive Director & Head-Global Product at Turning Point Therapeutics, Inc. and Senior Director-Strategic Alliance & Program at Wellspring Biosciences, Inc. Dr. Hu-Lowe obtained a doctorate degree from the University of Mississippi in 1992 and an undergraduate degree from Beijing Normal University in 1984.
Posizioni attive di Dana Hu-Lowe
| Società | Posizione | Inizio |
|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 01/11/2021 |
Precedenti posizioni note di Dana Hu-Lowe
| Società | Posizione | Fine |
|---|---|---|
| TURG POIN | Director/Board Member | 01/10/2021 |
| Wellspring Biosciences, Inc. | Corporate Officer/Principal | 01/03/2019 |
Formazione di Dana Hu-Lowe
| University of Mississippi | Doctorate Degree |
| Beijing Normal University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ADAGENE INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
| Wellspring Biosciences, Inc. |
- Borsa valori
- Insiders
- Dana Hu-Lowe
